A new expert consensus decision pathway from the American College of Cardiology (ACC) provides guidance around the management of myocarditis from diagnosis to follow-up. In light of recent advances in ...

The updated 2024-2025 mRNA COVID vaccine from Moderna does not appear to carry the same risk for myocarditis in young adults that the first mRNA COVID vaccines did, suggested research presented at the ...

The FDA updated warnings for Pfizer and Moderna COVID-19 vaccines to includes risks of myocarditis and pericarditis. A follow-up study showed some individuals who developed myocarditis after ...

Myocarditis has become a flashpoint in debates about COVID vaccines; however, new research suggests this rare heart inflammation is a window into how powerful immune technologies sometimes misfire in ...

One of the most widely known risks linked to the COVID-19 vaccine is myocarditis, especially in young males — and now a new Stanford study has shed some light on why this rare effect can occur.

Recommendations in the new ESC guidelines are largely consistent with those of the 2024 American College of Cardiology (ACC) expert consensus decision pathway on managing myocarditis, and a 2025 joint ...

Please provide your email address to receive an email when new articles are posted on . T-cell receptors in the hearts of patients with immunotherapy-induced myocarditis differed from those in their ...